INNOVA CAPTAB
Back to Balance Sheet
|
INNOVA CAPTAB Last 5 Year Sundry Debtors History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Sundry Debtors | ₹332 Cr | ₹288 Cr | ₹265 Cr | ₹213 Cr | ₹139 Cr |
What is the latest Sundry Debtors ratio of INNOVA CAPTAB ?
| Year | Sundry Debtors |
|---|---|
| Mar2025 | ₹332 Cr |
| Mar2024 | ₹288 Cr |
| Mar2023 | ₹265 Cr |
| Mar2022 | ₹213 Cr |
| Mar2021 | ₹139 Cr |
How is Sundry Debtors of INNOVA CAPTAB Trending?
| Years | Sundry Debtors | % Change | |
|---|---|---|---|
| Mar2025 | ₹332 Cr | 14.96 | |
| Mar2024 | ₹288 Cr | 8.77 | |
| Mar2023 | ₹265 Cr | 24.70 | |
| Mar2022 | ₹213 Cr | 53.51 | |
| Mar2021 | ₹139 Cr | - | |
Compare Sundry Debtors of peers of INNOVA CAPTAB
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| INNOVA CAPTAB | ₹4,011.4 Cr | -3.9% | -5.2% | -40.9% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹415,073.0 Cr | -0% | -3.2% | -5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹175,657.0 Cr | 4% | 5.2% | 11.9% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹134,121.0 Cr | 3.6% | 7% | 22% | Stock Analytics | |
| CIPLA | ₹118,431.0 Cr | -3.5% | -1.5% | -2.5% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹100,944.0 Cr | -3.2% | -3.3% | -10.6% | Stock Analytics | |
INNOVA CAPTAB Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| INNOVA CAPTAB | -3.9% |
-5.2% |
-40.9% |
| SENSEX | -2.6% |
-1.3% |
7.2% |
You may also like the below Video Courses